0 Ratings
ID

24571

Description

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Keywords

Versions (3)
  1. 8/6/17 8/6/17 -
  2. 8/8/17 8/8/17 -
  3. 8/8/17 8/8/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 6, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

    English

    concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

    1 forms  
    COPD CONCOMITANT MEDICATIONS
    Description

    COPD CONCOMITANT MEDICATIONS

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0024117
    Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
    Description

    COPD concomitant medication

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0024117
    If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.
    Description

    If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0024117
    Drug Name
    Description

    Trade name preferred.

    Data type

    text

    Alias
    UMLS CUI [1]
    C2360065
    Unit Dose
    Description

    unit dose

    Data type

    integer

    Alias
    UMLS CUI [1]
    C0869039
    Unit
    Description

    units of medication

    Data type

    integer

    Alias
    UMLS CUI [1]
    C1519795
    Frequency
    Description

    frequency of medication

    Data type

    text

    Alias
    UMLS CUI [1]
    C3476109
    Route
    Description

    medication routes

    Data type

    text

    Alias
    UMLS CUI [1]
    C0013153
    Start Date
    Description

    start date of medication

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0808070
    Taken prior to study?
    Description

    medication taken prior to study

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826667
    Stop Date
    Description

    stop date of medication

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0806020
    Ongoing medication?
    Description

    concomitant medication ongoing

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826666
    Was drug administered for an exacerbation?
    Description

    drug adminstered for a COPD exacerbation

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C3469597
    UMLS CUI [1,2]
    C0740304
    NON-COPD CONCOMITANT MEDICATIONS
    Description

    NON-COPD CONCOMITANT MEDICATIONS

    Alias
    UMLS CUI-1
    C2347852
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    Description

    medication that is not COPD-related

    Data type

    text

    Alias
    UMLS CUI [1]
    C2347852
    If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.
    Description

    If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.

    Alias
    UMLS CUI-1
    C2347852
    Drug name
    Description

    Trade name preferred.

    Data type

    text

    Alias
    UMLS CUI [1]
    C2360065
    Unit Dose
    Description

    unit dose

    Data type

    integer

    Alias
    UMLS CUI [1]
    C0869039
    Unit
    Description

    units of medication

    Data type

    integer

    Alias
    UMLS CUI [1]
    C1519795
    Frequency
    Description

    frequency of medication

    Data type

    text

    Alias
    UMLS CUI [1]
    C3476109
    Route
    Description

    medication routes

    Data type

    text

    Alias
    UMLS CUI [1]
    C0013153
    Reason for Medication
    Description

    reason for medication

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C0013227
    Start Date
    Description

    start date of medication

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0808070
    Taken prior to study?
    Description

    medication taken prior to study

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826667
    Stop Date
    Description

    stop date of medication

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0806020
    Ongoing medication?
    Description

    concomitant medication ongoing

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826666
    Back to the top of the page

    Similar models

    concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    COPD CONCOMITANT MEDICATIONS
    C2347852 (UMLS CUI-1)
    C0024117 (UMLS CUI-2)
    Item
    Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
    text
    C2347852 (UMLS CUI [1,1])
    C0024117 (UMLS CUI [1,2])
    COPD concomitant medication
    Code List
    Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item Group
    If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.
    C2347852 (UMLS CUI-1)
    C0024117 (UMLS CUI-2)
    medication name
    Item
    Drug Name
    text
    C2360065 (UMLS CUI [1])
    unit dose
    Item
    Unit Dose
    integer
    C0869039 (UMLS CUI [1])
    units of medication
    Item
    Unit
    integer
    C1519795 (UMLS CUI [1])
    frequency of medication
    Item
    Frequency
    text
    C3476109 (UMLS CUI [1])
    medication routes
    Item
    Route
    text
    C0013153 (UMLS CUI [1])
    start date of medication
    Item
    Start Date
    date
    C0013227 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    Item
    Taken prior to study?
    text
    C2826667 (UMLS CUI [1])
    medication taken prior to study
    Code List
    Taken prior to study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    stop date of medication
    Item
    Stop Date
    date
    C0013227 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Item
    Ongoing medication?
    text
    C2826666 (UMLS CUI [1])
    concomitant medication ongoing
    Code List
    Ongoing medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Was drug administered for an exacerbation?
    text
    C3469597 (UMLS CUI [1,1])
    C0740304 (UMLS CUI [1,2])
    drug adminstered for a COPD exacerbation
    Code List
    Was drug administered for an exacerbation?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item Group
    NON-COPD CONCOMITANT MEDICATIONS
    C2347852 (UMLS CUI-1)
    Item
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    text
    C2347852 (UMLS CUI [1])
    concomitant medication
    Code List
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item Group
    If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.
    C2347852 (UMLS CUI-1)
    medication name
    Item
    Drug name
    text
    C2360065 (UMLS CUI [1])
    unit dose
    Item
    Unit Dose
    integer
    C0869039 (UMLS CUI [1])
    units of medication
    Item
    Unit
    integer
    C1519795 (UMLS CUI [1])
    frequency of medication
    Item
    Frequency
    text
    C3476109 (UMLS CUI [1])
    medication routes
    Item
    Route
    text
    C0013153 (UMLS CUI [1])
    reason for medication
    Item
    Reason for Medication
    text
    C0392360 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    start date of medication
    Item
    Start Date
    date
    C0013227 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    Item
    Taken prior to study?
    text
    C2826667 (UMLS CUI [1])
    medication taken prior to study
    Code List
    Taken prior to study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    stop date of medication
    Item
    Stop Date
    date
    C0013227 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Item
    Ongoing medication?
    text
    C2826666 (UMLS CUI [1])
    concomitant medication ongoing
    Code List
    Ongoing medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial